Logo image of ACON

ACLARION INC (ACON) Stock Fundamental Analysis

USA - NASDAQ:ACON - US6551874091 - Common Stock

6.12 USD
+0.25 (+4.26%)
Last: 11/20/2025, 8:00:00 PM
Fundamental Rating

3

ACON gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 35 industry peers in the Health Care Technology industry. ACON has a great financial health rating, but its profitability evaluates not so good. ACON is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

In the past year ACON has reported negative net income.
In the past year ACON has reported a negative cash flow from operations.
In the past 5 years ACON always reported negative net income.
In the past 5 years ACON always reported negative operating cash flow.
ACON Yearly Net Income VS EBIT VS OCF VS FCFACON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 2024 -2M -4M -6M

1.2 Ratios

ACON's Return On Assets of -47.85% is on the low side compared to the rest of the industry. ACON is outperformed by 77.14% of its industry peers.
ACON's Return On Equity of -49.76% is in line compared to the rest of the industry. ACON outperforms 48.57% of its industry peers.
Industry RankSector Rank
ROA -47.85%
ROE -49.76%
ROIC N/A
ROA(3y)-263.04%
ROA(5y)-305.81%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ACON Yearly ROA, ROE, ROICACON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 2024 0 500 -500

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ACON so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ACON Yearly Profit, Operating, Gross MarginsACON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 2024 -5K -10K -15K

7

2. Health

2.1 Basic Checks

ACON does not have a ROIC to compare to the WACC, probably because it is not profitable.
ACON has more shares outstanding than it did 1 year ago.
There is no outstanding debt for ACON. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ACON Yearly Shares OutstandingACON Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2M 4M 6M
ACON Yearly Total Debt VS Total AssetsACON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M

2.2 Solvency

Based on the Altman-Z score of -1.52, we must say that ACON is in the distress zone and has some risk of bankruptcy.
ACON has a Altman-Z score of -1.52. This is in the lower half of the industry: ACON underperforms 60.00% of its industry peers.
ACON has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -1.52
ROIC/WACCN/A
WACC10.25%
ACON Yearly LT Debt VS Equity VS FCFACON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 2024 0 2M -2M -4M -6M

2.3 Liquidity

A Current Ratio of 23.81 indicates that ACON has no problem at all paying its short term obligations.
ACON's Current ratio of 23.81 is amongst the best of the industry. ACON outperforms 100.00% of its industry peers.
A Quick Ratio of 23.81 indicates that ACON has no problem at all paying its short term obligations.
ACON has a better Quick ratio (23.81) than 100.00% of its industry peers.
Industry RankSector Rank
Current Ratio 23.81
Quick Ratio 23.81
ACON Yearly Current Assets VS Current LiabilitesACON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2M 4M 6M 8M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 93.02% over the past year.
ACON shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 16.48%.
Measured over the past years, ACON shows a decrease in Revenue. The Revenue has been decreasing by -8.83% on average per year.
EPS 1Y (TTM)93.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.8%
Revenue 1Y (TTM)16.48%
Revenue growth 3Y-8.83%
Revenue growth 5YN/A
Sales Q2Q%76.12%

3.2 Future

ACON is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.36% yearly.
ACON is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 121.56% yearly.
EPS Next Y99.81%
EPS Next 2Y41.36%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year100%
Revenue Next 2Y121.57%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ACON Yearly Revenue VS EstimatesACON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 100K 200K 300K
ACON Yearly EPS VS EstimatesACON Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 -100K -200K -300K

1

4. Valuation

4.1 Price/Earnings Ratio

ACON reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ACON. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ACON Price Earnings VS Forward Price EarningsACON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ACON Per share dataACON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -500 -1K -1.5K -2K

4.3 Compensation for Growth

A more expensive valuation may be justified as ACON's earnings are expected to grow with 41.36% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.36%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

ACON does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

ACLARION INC

NASDAQ:ACON (11/20/2025, 8:00:00 PM)

6.12

+0.25 (+4.26%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)08-14 2025-08-14/dmh
Earnings (Next)N/A N/A
Inst Owners0.77%
Inst Owner Change583.31%
Ins Owners0%
Ins Owner Change0%
Market Cap3.98M
Revenue(TTM)62.90K
Net Income(TTM)-7.06M
Analysts82.86
Price Target20.4 (233.33%)
Short Float %5.56%
Short Ratio0.21
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)40.04%
Min EPS beat(2)-19.3%
Max EPS beat(2)99.37%
EPS beat(4)3
Avg EPS beat(4)31.34%
Min EPS beat(4)-19.3%
Max EPS beat(4)99.37%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-37.4%
Min Revenue beat(2)-37.94%
Max Revenue beat(2)-36.86%
Revenue beat(4)0
Avg Revenue beat(4)-39.57%
Min Revenue beat(4)-45.1%
Max Revenue beat(4)-36.86%
Revenue beat(8)0
Avg Revenue beat(8)-53.35%
Revenue beat(12)2
Avg Revenue beat(12)-37.66%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 63.24
P/FCF N/A
P/OCF N/A
P/B 0.28
P/tB 0.31
EV/EBITDA N/A
EPS(TTM)-2155.52
EYN/A
EPS(NY)-12.37
Fwd EYN/A
FCF(TTM)-10.22
FCFYN/A
OCF(TTM)-9.78
OCFYN/A
SpS0.1
BVpS21.83
TBVpS19.82
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -47.85%
ROE -49.76%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-263.04%
ROA(5y)-305.81%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 136.59%
Cap/Sales 455.8%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 23.81
Quick Ratio 23.81
Altman-Z -1.52
F-Score5
WACC10.25%
ROIC/WACCN/A
Cap/Depr(3y)128.54%
Cap/Depr(5y)106.31%
Cap/Sales(3y)402.91%
Cap/Sales(5y)349.24%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)93.02%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%99.8%
EPS Next Y99.81%
EPS Next 2Y41.36%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)16.48%
Revenue growth 3Y-8.83%
Revenue growth 5YN/A
Sales Q2Q%76.12%
Revenue Next Year100%
Revenue Next 2Y121.57%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-34.71%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-52.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-51.53%
OCF growth 3YN/A
OCF growth 5YN/A

ACLARION INC / ACON FAQ

What is the ChartMill fundamental rating of ACLARION INC (ACON) stock?

ChartMill assigns a fundamental rating of 3 / 10 to ACON.


What is the valuation status for ACON stock?

ChartMill assigns a valuation rating of 1 / 10 to ACLARION INC (ACON). This can be considered as Overvalued.


How profitable is ACLARION INC (ACON) stock?

ACLARION INC (ACON) has a profitability rating of 0 / 10.


Can you provide the expected EPS growth for ACON stock?

The Earnings per Share (EPS) of ACLARION INC (ACON) is expected to grow by 99.81% in the next year.